Q32 Bio Inc Sustainability Reports
Q32 Bio Inc. is a clinical-stage biotechnology company developing novel biologic therapeutics designed to restore healthy immune balance. The company primarily focuses on advancing therapies for autoimmune and inflammatory diseases, such as alopecia areata.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300RWKPJEFTM3K452
FIGI: BBG00CTTJWS7
1 reports from 2024 to 2024